China is recovering from the historical shutdown although the CVOD-19 is still spreading into many countries. Farmers start their year routine as usual and the lonely cities are getting busier. The single-digit of new cases of CVOD-19 in the last two weeks gives Beijing confidence to restart the economic engine, that is said, 6% of GDP growth and buying more farm products from President Donald Trump are still goals and promises of China’s 2020. The chance is that China released an aggressive guideline for healthcare reform two weeks ago and estimated USD 30 billion governmental investment is going to spend on primary healthcare infrastructure and new technologies, the confusion is that how healthcare innovators in North America, such as you, could catch them up and make difference in there?

Beijing released 2020 healthcare reform guideline on Feb 14; each of them has long term impact not just for healthcare industry, but also for wellbeing of people in China. The move of this reform is not a one guy show, it requires global collaboration. The estimated investment is over USD 30 billion each year and primary care is key, I sum as following, for details, please refer to my article on linkedin “China’s reform on public health and healthcare system after coronavirus epidemic”:

1. Build China’s own “biological shield “to safeguard national security.
2. Promote “efficient and seamless convergence” between public health and medical services.
3. Shift its focus to primary care; focus on strengthening the community public health forces, so as to enable general practitioners to play the role of prevention and treatment.
4. Strengthen scientific research, disease control, and clinical treatment coordination anti-epidemic mechanism, strengthen information sharing and ensure that the three fronts of health care are highly coordinated and mutually supportive.
5. Improve the classification, stratification, diversion, and treatment mechanism to ensure that the epidemic response orderly.
6. The scientific and technological innovation mechanism should give full play to the role of advanced digital technologies such as big data, artificial intelligence, and cloud computing in epidemic surveillance and analysis, virus traceability, and resource allocation, so as to promote the modernization of epidemic prevention through information technology.
7. The mechanism of emergency medical assistance and the mechanism of exemption of medical expenses for special groups and specific diseases should play the role of State financial and social security to reduce the burden of public visits and hospital treatment.

In February, I talked to 19 founders or CEO of healthcare clients from coast to coast, they are definitely outstanding both in technologies innovation and market development in U.S and Canada. However, the capital market does not say the same story, many of their stocks are devalued for a period of time. Over ¾ of CEOs think the potential of China market is three times more but fear of uncertainties to a new market may keep them in here. The most concerned 3 questions are:

1. Pro or Con of Distributing to China market or selling to China?
2. How intellectual property can be well protected?
3. How to use cross-border capital to support local R&D while exploiting a new market?